Retina Consultants of Hawaii

Retina Consultants of Hawaii (RCH) is a premier medical practice and clinical research center specializing in the diagnosis and treatment of vitreoretinal diseases. Founded by Dr. Gregg Kokame, the organization operates multiple clinics across the Hawaiian Islands and is globally recognized for its extensive involvement in Phase 1 through Phase 3 clinical trials. Through its research arm, the Hawaii Macula and Retina Institute, RCH collaborates with major pharmaceutical companies to develop and test innovative therapies for conditions such as macular degeneration and diabetic retinopathy. In 2022, the practice joined Retina Consultants of America (RCA), a national network of elite retina specialists backed by Webster Equity Partners. RCH remains a leading site for ophthalmic drug development, providing patients in the Pacific region with access to cutting-edge treatments including gene therapies and novel biologics.